powered by
▸
healthparse
Search
Cohort Builder
Tools
▾
KOL Finder
Territories
Drug Compare
AI Query
Browse
▾
By state
By specialty
Pricing
Search
Cohort Builder
Tools
KOL Finder
Territories
Drug Compare
AI Query
Browse
By state
By specialty
Pricing
PROVIDER PROFILE · NPI 1770800732
Robert Daly
M.D., M.B.A.
Medical Oncology
New York,
NY
I
CROSS-REFERENCE
Related data on other Healthparse brands
ProviderScore
OIG/SAM exclusion screening, sanctions history
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024
Total received
$1K
Payment records
1
By payment type
Consulting Fee
$1K
QUALITY · MIPS · 2024
Final MIPS score
75.5
Quality
60.6
Cost
73.9
Improvement activities
40.0
Promoting interop.
0.0
Payment adjustment
0.02%
Group
PRESCRIBING · PART D · 2024
Total Rx claims
419
Beneficiaries
—
Total drug cost
$2.5M
Distinct drugs
12
Brand share
39.6%
Top prescribed drugs
Osimertinib Mesylate
133 claims
Dexamethasone
115 claims
Ondansetron Hcl
33 claims
Prednisone
23 claims
Olanzapine
20 claims
MEDICARE UTILIZATION · PART B · 2024
Total beneficiaries
292
Unique beneficiaries
—
Total services
662
Distinct HCPCS
6
Medicare payment
$49K
Peer benchmark
Q1
Q2
Q3
Q4
Q5
Total Medicare services vs. 506 Medical Oncology providers in NY — above median (cohort median 458).